LoginSignup
Pfizer logo

Pfizer Stock

StockStock
ISIN: US7170811035
Ticker: PFE
US7170811035
PFE

Price

Historical dividends and forecast

All dividend data

Pfizer has so far distributed $1.26 in 2024. The next dividend will be paid on 02.12.2024

$0.754

CHART BY

Frequently asked questions

What is Pfizer's market capitalization?

The market capitalization of Pfizer is $161.61B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Pfizer's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Pfizer is 38.54. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Pfizer?

Pfizer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.74. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Pfizer's stock?

Currently, 24 analysts cover Pfizer's stock, with a consensus target price of $31.49. Analyst ratings provide insights into the stock's expected performance.

What is Pfizer's revenue over the trailing twelve months?

Over the trailing twelve months, Pfizer reported a revenue of $60.11B.

Is Pfizer paying dividends?

Yes, Pfizer is paying dividends. The next payment is scheduled for 02.12.2024, with an expected amount of .

What is the EBITDA for Pfizer?

Pfizer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $19.59B. EBITDA measures the company's overall financial performance.

What is the 5-year beta of Pfizer's stock?

The 5-year beta for Pfizer is 0.65. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Pfizer have, and what sector and industry does it belong to?

Pfizer employs approximately 88,000 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Pfizer's shares?

The free float of Pfizer is 5.66B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $161.61B

5Y beta

 0.65

EPS (TTM)

 $0.74

Free Float

 5.66B

P/E ratio (TTM)

 38.54

Revenue (TTM)

 $60.11B

EBITDA (TTM)

 $19.59B

Pricing

1D span
$28.25$28.63
52W span
$25.20$31.54

Analyst Ratings

The price target is $31.49 and the stock is covered by 24 analysts.

Buy

9

Hold

15

Sell

0

Information

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.

88,000

Biotechnology & Drugs

Health Care

Identifier

ISIN

US7170811035

Primary Ticker

PFE

Knockouts

Join the conversation
Sign upLogin